Global Cloning and Mutagenesis Market to Register Remarkable Growth Rate in Asia-Pacific till 2026

(The Express Wire via Comtex)

Growing number of people being affected by chronic diseases is likely to be the key driver in the global "cloning and mutagenesis"market growth. The World Health Organization estimates that by 2020, the prevalence of chronic diseases will rise by 57%. The primary reason for this staggering figure is the increasingly sedentary lifestyle being adopted by people in urban areas. Adding to this are factors such as unhealthy food habits, smoking and drinking, and lack of exercise. As a result, chronic diseases such as obesity and diabetes are on the rise globally. For example, WHO statistics reveal that there were 650 million obese adults (18 years and older) in 2016. These factors will favor the expansion of the global cloning and mutagenesis market size during the forecast period.

The research report gives an entire study of the Cloning and Mutagenesis Market leaders with key statistics like sales, revenue, price, product picture and specifications, contact information, cost, capacity, production and company profile. The report offers critical information at the state of the enterprise. Marketing channels and development trends of the market is also well-found inside the report, making it a valuable source of information and path for agencies and individuals.

Key Stakeholders:

  • Raw material suppliers
  • Distributors/traders/wholesalers/suppliers
  • Regulatory bodies, including government agencies and NGO
  • Commercial research and development (RandD) institutions
  • Importers and exporters
  • Government organizations, research organizations, and consulting firms
  • Trade associations and industry bodies
  • End-use industries

Request a Sample Copy of the Research Report:

Increasing Research Activities in Cancer and Other Rare Disorders to Fuel the Market

The global cloning and mutagenesis market is slated for substantial growth owing to the extensive and intensive research being undertaken to develop therapies for cancer and other rare disorders. For example, in 2017, clinical trials were conducted at the Royal Marsden Hospital in London on organoids. These are three-dimensional structures derived from the patient’s cancer cells and are expected to imitate a tumour’s response, representing a cloning technique. This can enable doctors to deliver more targeted and accurate treatment to cancer patients. Similarly, the International Rare Diseases Research Consortium (IRDiRC) has set itself a goal of developing 200 therapies by 2020 for different rare diseases. This bodes well for the global cloning and mutagenesis market revenue as public-funded research are getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development.

Leading Players operating in the Cloning and Mutagenesis Market are:

  • Agilent Technologies, Inc.
  • Genomax Technologies Pte Ltd.
  • Transgen Biotech Co., LTD
  • Thermo Fisher Scientific
  • EZBioscience
  • Jena Bioscience GmbH
  • New England Biolabs, abm Inc.
  • GENEWIZ Inc.
  • Takara Bio Inc.

Advancements in Stem Cell Research to Propel the Market in North America

Regionally, North America is anticipated to have a dominant hold on the global cloning and mutagenesis market share in the forecast period. The primary reasons for this being increasing investment in stem cell and cancer research and rising number of biotechnology companies in the region. In Asia-Pacific, a high CAGR is projected on account of increasing prevalence of chronic diseases, evolving healthcare systems, and rising adoption of personalized medication services.

Have Any Query? Ask Our Experts:

Global Cloning and Mutagenesis Market Segmentation:

By Technique

  • Blunt End Cloning
  • Topo PCR Cloning
  • Seamless Cloning
  • Site-Directed Mutagenesis
  • Others

By Product

  • Cloning Kits
  • Mutagenesis Kits

By End User

  • Academic and Research Institutes
  • Biotechnology Companies
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Reasons to Purchase this Report:

  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Comprehensive analysis of the Aesthetic Implants Market growth drivers, obstacles, opportunities, and other related challenges.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Order Full Report:

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights™


Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Global Cloning and Mutagenesis Market to Register Remarkable Growth Rate in Asia-Pacific till 2026

comtex tracking